BIOCURE TECHNOLOGY INC.
Healthcare · EUR · F
Price
€0.018
Cap
€960,835
Earnings
—
30d Trend
+0.0%
174% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 42×Macro 0.99 (−1%)=42
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 80%
BRAIN47 HORIZON ANALYSIS
Moderate long-term case — not compelling enough for a multi-year commitment
BRAIN47'S ASSESSMENT
I rate BIOCURE TECHNOLOGY INC. at 42/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is quality at 59/100. I classify this as a speculative position with the strongest thesis on a long-term horizon.
PAST PERFORMANCE
1 MONTH
—
3 MONTHS
—
12 MONTHS
-18.2%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Moderate long-term case — not compelling enough for a multi-year commitment. Quality (59) and Fundamentals (50) are the primary strengths. I note that technical is the weakest area at 34/100 — this warrants monitoring. Historical volatility is elevated at 174%. I classify this as a speculative position — elevated volatility at 174% and smaller market cap define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.